Search Results for "Biochemistry Leukemia"

01:32 EDT 27th April 2015 | BioPortfolio

Matching Channels

Chronic Leukemia

Chronic leukemia is a long term increase of abnormal white blood cells. It can be classed as myelogenous or lymphocytic leukemia. For more information see the Leukemia pages Add the Leukemia New...

Acute Leukemia

Acute leukemia occurs when a hematopoietic stem cell undergoes malignant transformation into a primitive, undifferentiated cell with abnormal longevity. These lymphocytes (acute lymphocytic leukemia...

Acute Myelocytic Leukemia AML

Acute myelocytic leukemia is a life-threatening disease in which the neutrophil, basophil, eosinophil, and monocyte precursors become cancerous and rapidly replace normal cells in the bone marrow. ...

Acute Lymphocytic Leukemia ALL

Acute lymphocytic leukemia (ALL) is a life-threatening disease in which the cells that normally develop into lymphocytes become cancerous and rapidly replace normal cells in the bone marrow. ALL acc...

Chronic Myelocytic Leukemia CML

Chronic myelocytic leukemia is the resulting disease when neutrophil, basophil, eosinophil, and monocyte progenitors become cancerous. It is usually caused by the presence of the Philadelphia chromo...

Matching News

UF researchers discover leukemia’s hiding places

In patients with leukemia, cancer cells can embed within the walls of blood vessels and hide from chemotherapy, according to a University of Florida study published in Leukemia. Now, UF Health researc...

Paucity of Somatic Mutations in Aggressive Childhood Leukemia

In-depth DNA sequencing and RNA expression analysis shows that a particularly aggressive form of infant and childhood leukemia--mixed-lineage leukemia-rearranged gene (MLL-R) acute lymphoblastic leuke...

Researchers effectively, safely overcome radiation resistance in leukemia with an engineered precision medicine

Improved survival rates have been demonstrated in mouse models of aggressive human leukemia using leukemia cells taken directly from patients, according to a new study.

Promising drug a 'new paradigm' for treating leukemia

Researchers at the University of Virginia School of Medicine have developed a compound that delays leukemia in mice and effectively kills leukemia cells in human tissue samples, raising hopes that the...

Leukemia like Achilles, has its own weakness

Leukemia cells from patients suffering from chronic myeloid leukemia, especially in the advanced stage, lack one of the proteins: the famous BRCA1. Importantly, the protein is not present even if the ...

Leukemia-associated mutations almost inevitable as we age

(Wellcome Trust Sanger Institute) It's almost inevitable that we'll develop mutations associated with leukemia as we age, according to research today in Cell Reports. These mutations are more common t...

Leukemia Partnering 2009-2014

Recently added to the BioPortfolio report store, Leukemia Partnering 2009-2014 is a new report from Current Partnering published on 2014-10-31. This 150+-page report is available from $995. The Leuk...

Key mechanism, potential target to prevent leukemia found

Two proteins that appear crucial to the development -- and patient relapse -- of acute myeloid leukemia have been found by researchers. They have also shown they can block the development of leukemia ...

Matching PubMed Articles

Faggot-like cells observed in acute myeloid leukemia with myelodysplasia-related changes mimicking acute promyelocytic leukemia.

Anti-proliferative activity of 6-O-acyl-d-allose against the human leukemia MOLT-4F cell line.

The anti-proliferative activities of the 6-O-acyl derivatives of d-allose against the human leukemia MOLT-4F cell line were examined. The activity of the 6-O-dodecanoyl derivative (3) was approximatel...

The characterization and role of leukemia cell-derived dendritic cells in immunotherapy for leukemic diseases.

Usually, an effective anti-leukemia immune response cannot be initiated effectively in patients with leukemia. This is probably related to immunosuppression due to chemotherapy, down-regulation of maj...

Feasibility and Outcome of the Hyper-CVAD Regimen in Patients With Adult Acute Lymphoblastic Leukemia.

Current chemotherapy regimens for adults with acute lymphoblastic leukemia (ALL) result in high rates of complete remission (CR), but relapses are still frequent.

Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia.

Treatment failure in acute myeloid leukemia is probably caused by the presence of leukemia initiating cells, also referred to as leukemic stem cells, at diagnosis and their persistence after therapy. ...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement